Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk early breast cancer Seven-year results from the ...
INDIANAPOLIS - Eli Lilly and Company (NYSE:LLY), a prominent player in the pharmaceuticals industry with a market capitalization of $735 billion and impressive revenue growth of 37% over the last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback